Research and experimental development on natural sciences and engineering
ADJUTEC PHARMA AS
Operating profit
NOK −2.1m
Equity
NOK 33.3m
Incorporated
2019
Employees
5
Share capital
NOK 58,000
Key figures · 2024
Current ratio
-8.75
Equity ratio
76.8%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Return on assets (%%) | -4.8% | |
| Likviditet | ||
| Current ratio | -8.75 | |
| Working capital | 9.4m | |
| Soliditet | ||
| Equity ratio (%%) | 76.8% | |
| Debt-to-equity ratio | 0.30 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.